Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of APG-5918. [Phase 1]

View source ↗

Summary

This document announces an ongoing Phase 1 clinical trial evaluating APG-5918 for anemia, focusing on safety, pharmacokinetics, and preliminary efficacy with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Drugs mentioned

• APG-5918

Snippet

Sponsor: Ascentage Pharma Group Inc. | Conditions: Anemia | Phase 1 | Status: RECRUITING